OnPAR provides innovative and exceptional research applications with a second opportunity for funding.
Leidos will match high-scoring, unfunded National Institutes of Health (NIH) proposals with private biomedical foundations and/or industries seeking to fund promising research. Foundations will have access to peer-reviewed research proposals that directly relate to their funding priorities, industry will have access to a rich pipeline of early stage and translational research proposals that align with its priorities, while applicants with strong research proposals will be provided with a second opportunity to secure funding. The foundations, industries, applicants, and NIH all will benefit from this synergy.
Each year, hundreds of innovative, high-scoring research applications are left unfunded.
Currently, NIH funds approximately 20 percent of grant applications, whereas it traditionally funded about a third. This lower percentage leaves many outstanding research projects with the opportunity for a second chance.